Part,  Chapter, Paragraph

  1    -,     1            |                  all the available data (see Appendix 5) for preparing
  2    I,     2. 10.  1    |               the field of cancer. As we see a clear need to adjust concepts
  3    I,     2. 10.  2(4) |                                          See: htt m.~
  4    I,     2. 10.  2(5) |                                          See: htt t. Org/44.~
  5    I,     3.  2        |                   and Malta. Sweden will see a population growth between
  6   II,     4.  1        |                France and Italy in 2005 (see above).~ ~All health expectancy
  7   II,     4.  1        |              through the EHEMU projects (see www. eu and www. ~ ~Further
  8   II,     5.  1.  1    |                  conditions and problems~See section 5.6.~Respiratory
  9   II,     5.  2.  3    |                 Table 5.2.4; here we can see mean attack rates of 10-
 10   II,     5.  2.  4    |           Eastern and Eastern countries (see also Chapter 8).~ ~Table
 11   II,     5.  2.  4    |          glycaemia (Panico et al, 2008) (see Chapter 5.1.4). Recent evidence
 12   II,     5.  2.  4    |                   in predicting CV risk (see also Chapter 10).~ ~Table
 13   II,     5.  2.  4    |                 and psychosocial stress (see the attached European Heart
 14   II,     5.  2.  4    |                 have never been smokers (see Chapter 5.1.2.).~Unfortunately,
 15   II,     5.  2.  5    |          body weight) or the environment see Sections 5.1. or 5.2.; for
 16   II,     5.  2.  5    |                    for diabetes mellitus see Section 3.1.5. Annex 1 is
 17   II,     5.  3.  2    |            cancer registration coverage (see above). Yet in several EU
 18   II,     5.  3.  2    |           estimates of cancer incidence. See: http://www.iarc.fr~ ~ENCR –
 19   II,     5.  3.  2    |       health-care planning and research. See: http://www.encr.com.fr/~ ~
 20   II,     5.  3.  2    |              health information systems. See: www.tumori.net/eurochip/~ ~
 21   II,     5.  3.  2    |                 into the current decade. See: http://www.eurocare.it/~ ~
 22   II,     5.  3.  2    |                to EU 2015 Cancer Target. See: http://www.eurocanplus.
 23   II,     5.  3.  2    |                and guidelines on cancer. See: http://www.esmo.org/resources/
 24   II,     5.  3.  2    |        availability of new cancer drugs. See: http://annonc.oxfordjournals.
 25   II,     5.  3.  7    |           disease (Boyle et al, 2003).~ ~See Chapter 10 for primary prevention
 26   II,     5.  3.  7    |         environment. For further details see Chapter 4.14.~ ~
 27   II,     5.  3.  7    |              number of EU Member States (see Table 5.3.2) consider national
 28   II,     5.  4.  2    |                   Greenfield et al 2004, see Table 5.4.2), only three
 29   II,     5.  4.  2    |               Glycated HaemoglobinHbA1c, see Armesto et al. 2006) due
 30   II,     5.  4.  6    |                  use of BIRO technology (seeFuture developments”).~
 31   II,     5.  4.  6    |                  and healthy lifestyles. See Chapter 5.13. on overweight
 32   II,     5.  4.  6    |           pressure and high cholesterol, see Chapter 5.2.4. and for other
 33   II,     5.  4.  6    |               and for other risk factors see Chapter 10.~To prevent the
 34   II,     5.  4.  6    |               Luxembourg, 1-2 June 2006 (see Table 5.4.1);~ ~Table 5.
 35   II,     5.  5.  1    |               mental health data in HfA, see also the introductory Section
 36   II,     5.  5.  3    |       in-patients per 1,000 populations (see Figure 5.5.3.3.2), the value
 37   II,     5.  5.  3    |             AGREE Collaboration, 2003) – see table 5.5.3.2.4.~Table 5.
 38   II,     5.  5.  3    |                  as for outpatient care (see Table 5.5.3.3.6). Since
 39   II,     5.  5.  3    |           reported in incidence studies (see above).~ ~Table 5.5.3.4.
 40   II,     5.  5.  3    |                 of Good Practice on MS ( see below) calls for information
 41   II,     5.  6.  3    |          referral for (Lin et al, 2000), see physiotherapists and complementary
 42   II,     5.  7.  5    |          policies~ ~Primary prevention~ ~See Chapter 8~ ~Secondary prevention~ ~
 43   II,     5.  7.  6    |         improving organ donation rates ( see also the Chapter 9.2. on
 44   II,     5.  9.  5    |            lifestyles or the environment see Chapter 5. A key message
 45   II,     5. 10.  2    |             under Community legislation (see section 5). EuroPrevall
 46   II,     5. 10.  3    |                  are intolerant to food (see section 5.10.3.1.) and the
 47   II,     5. 11.  3    |                 cell tumours and others (See Chapter 4.3).~Some skin
 48   II,     5. 11.  3    |              such as metals in piercing (see Focus Box), perfumes and
 49   II,     5. 11.  3    |              joint European enterprises (see also Chapter 7 on “Rare Diseases”).~ ~
 50   II,     5. 12.  4    |                  HBV and HCV) infection (see also Chapter 6) and alcohol
 51   II,     5. 12.  4    |            association with HBV and HCV (see Chapter 6), cirrhosis mortality
 52   II,     5. 12.  5    |             control of HCV transmission (see Chapter 6) and of alcohol
 53   II,     5. 12.  5    |                  all European countries.~See Chapter 8 for what concerns
 54   II,     5. 12.  5    |             cause of disease and death ( see also Chapter 6).~ ~There
 55   II,     5. 13        |               For the quoted references, see Chapter 10.2.1.7.~ ~ ~
 56   II,     5. 14.  5    |               For the control of smoking see Chapter 8; for the control
 57   II,     5. 14.  5    |            excessive alcohol consumption see Chapter 8 ; and for diabetes
 58   II,     5. 14.  5    |                and for diabetes mellitus see Chapter 5.4.~It is possible
 59   II,     5. 15.  1    |              data are very much lacking (See: htt ~ ~Depending on the
 60   II,     5. 15.  5    |           initiatives on rare diseases.~(see: htt 93 and http ~ ~
 61   II,     6.  3.  1    |             infected, falls ill, goes to see a doctor, is diagnosed,
 62   II,     6.  3.  4    |                  drug-resistant disease (see section on antimicrobial
 63   II,     7.  2.  1    |                  reliability and quality see the ANAMORT project (htt ~ ~
 64   II,     7.  2.  2    |              discharge data for injuries see the final report of the
 65   II,     7.  3        |         Statistics summary 20032005” (see KfV, 2007)1. See also the
 66   II,     7.  3        |                  2005” (see KfV, 2007)1. See also the executive summary
 67   II,     7.  3.  4    |                place of occurrence etc. (see also “IDB” in Chapter 6.
 68   II,     7.  3.  5    |                 medically treated cases (See Table 7.1).~ ~Suicide and
 69   II,     7.  3.  5    |            almost 61 000 people a yearsee Figure 7.2 ) In Europe suicide
 70   II,     7.  4        |          standard of injury indicators.~(See: htt ~ ~Injury surveillance
 71   II,     7.  4.  3    |                  an injury (Figure 7.20; see also Figure 7.8. Fatalities
 72   II,     7.  4.  4    |                due to sports activities (see Figure 7.14).This means
 73   II,     7.  4.  4    |           gymnastics and aerobics (7%). (see Figure 7.21).Swimming and
 74   II,     8.  1.  2(1) |             European Statistical System, see: htt AL~
 75   II,     8.  1.  5(2) |                                   Please see: htt ml~
 76   II,     8.  2.  1    |                  of health inequalities (see the chapter on policies
 77   II,     8.  2.  1(8) |                                          See : ww rg~
 78   II,     8.  2.  3    |                  Countries in the world (see a list of studies with their
 79   II,     9            |                  and maternal education (see above). Data on the first
 80   II,     9            |                       interactive data) (see also Section 10.2).~ ~Cannabis
 81   II,     9            |                       interactive data) (see also Section 10.2).~ ~Sexual
 82   II,     9.  1        |                nearly half of the cases (see chapter 9.3.2).~ ~This burden
 83   II,     9.  1.  1    |                 are not reproduced here (see below). The remaining 25%
 84   II,     9.  1.  1    |               Congenital malformations~ ~See Chapter 9.1.2 for a detailed
 85   II,     9.  1.  1    |         synthesis of available knowledge see Table 9.1 and the section
 86   II,     9.  1.  1    |         differently in EU Member States. See Chapter 9.3.2 for more information.~ ~ ~
 87   II,     9.  1.  2    |                elsewhere in this Report (see Chapter 5). Metabolic diseases
 88   II,     9.  1.  2    |               registers in 20 countries (see Table 9.1.2.2.1), covering
 89   II,     9.  1.  2    |                 in others TOPFA is rare (see above). This has resulted
 90   II,     9.  1.  2    |                    For main risk factors see Table 9.1a.~ ~Table 9.1a.
 91   II,     9.  1.  2    |            entities. Most rare diseases (see Chapter 5.15) are congenital.
 92   II,     9.  2.  2    |                  its youngest age-group (see: htt ~ ~WHO (European Regional
 93   II,     9.  2.  2    |               definitions is important. (see:~www ~ ~European Commission:
 94   II,     9.  2.  3    |               countries in recent years (see Chapter 4.1). Congenital
 95   II,     9.  2.  3    |                of mortality in neonates (see Chapter 4.2), and accidents
 96   II,     9.  2.  3    |            accidents for 5-14 year olds (see Chapter 7).~ ~Cancer: Tumors
 97   II,     9.  2.  3    |                 their health (WHO 2005c)(see also Chapter 9.3).~ ~The
 98   II,     9.  2.  3    |            increase in type two diabetes(see also Chapter 5).~ ~Excess
 99   II,     9.  2.  3    |             reasons for under-reporting (see below).~ ~There are frequently
100   II,     9.  2.  4    |          identified for children health (see Table 9.1b.). Equally important -
101   II,     9.  2.  4    |                  and maternal education (see above). Data on the first
102   II,     9.  2.  4    |                       interactive data) (see also Section 10.2).~ ~Cannabis
103   II,     9.  2.  4    |                       interactive data) (see also Section 10.2).~ ~Sexual
104   II,     9.  3.  1    |               dealt with in this Chapter see Chapter 9.5.~ ~ ~
105   II,     9.  3.  1    |          accidents as compared to women (see Chapter on Accidents), with
106   II,     9.  3.  1    |               concerning health services see Chapter 11.~ ~
107   II,     9.  3.  2    |         synthesis of available knowledge see Table 9.1a.~ ~The EURO-PERISTAT
108   II,     9.  4.  3    |                  and more healthy years (see above), too many years are
109   II,     9.  4.  3    |          significant risk factor in men (see chapter on dementia for
110   II,     9.  4.  5    |                Indeed, some commentators see the creation of integrated
111   II,     9.  5.  2    |                 Injuries and Accidents).~See also section 9.2 for additional
112   II,     9.  5.  3    |              Statistics On-line, 2007). (See Figure 9.5.3) Carers can
113   II,     9.  5.  3    |      femininities can limit the way they see themselves as male and female (
114   II,     9.  5.  3    |                 and tend to stay longer (See: htt ~ ~
115  III,    10.  2.  1    |                 of deaths in both sexes (see Chapter 5.2.). Smoking contributes
116  III,    10.  2.  1    |                  et al., 1998).~Cancers (see Chapter 5.3) of the respiratory
117  III,    10.  2.  1    |                   Mortality due to COPD (see Chapter 5.7) varies from
118  III,    10.  2.  1(1) |         Substances. (For further details see http://eldd.emcdda.europa.
119  III,    10.  2.  1(5) |                                          See EMCDDA’s 2006 selected issues
120  III,    10.  2.  1    |               highest prevalence levels. See Figure 10.2.1.3.3 for trends
121  III,    10.  2.  1(7) |                                          See Figure GPS-34 in the 2007
122  III,    10.  2.  1(8) |                      For further details see http ds~
123  III,    10.  2.  1    |               and more highly prevalent. See Figure 10.2.1.3.6 for national
124  III,    10.  2.  1(13)|                                          See reference (Bargagli, et
125  III,    10.  2.  1(14)|         generally as limited proportion (see the 2006 statistical bulletin
126  III,    10.  2.  1(15)|                                          See Table DRD-2 (i), Table DRD-3
127  III,    10.  2.  1(16)|                                          See Figure DRD-1 in 2007 statistical
128  III,    10.  2.  1(19)|                                          See Figure HSR-3 in the statistical
129  III,    10.  2.  1    |                InfoBase data repository (see above).~ ~c) Reliable trend
130  III,    10.  2.  1    |           adolescents~ ~The HBSC survey (see above) measured participation
131  III,    10.  2.  1    |               dealt with in this Report (see section 5.2, 5.3 and 5.4),
132  III,    10.  2.  2    |                  details and references, see Chapter 5.2.~ ~ ~
133  III,    10.  2.  3    |                  details and references, see Chapter 5.2.~ ~ ~
134  III,    10.  2.  4    |                  rare genetic disorders (see Chapter 7 on Rare Diseases).
135  III,    10.  2.  4    |                et al, 2006): by this, we see a shift from a disease-specific
136  III,    10.  2.  4    |                the CYP system, we do not see any Public Health oriented
137  III,    10.  2.  4    |              more than indicates that we see an increasing individualisation
138  III,    10.  2.  5    |                  in different age groups see Chapter 9.~ ~
139  III,    10.  3.  2    |             major economic activities in SEE and the EECAA region, where
140  III,    10.  3.  2    |             majorSeveso II accidents” (see below) reported for the
141  III,    10.  3.  2    |              neurodevelopment disorders (see also chapters on air pollution
142  III,    10.  3.  2    |                international conventions see Annex 1). Producers and
143  III,    10.  3.  2    |           Asia-Europe Environment Forum. See: htt ~ ~Barbante C, et al (
144  III,    10.  3.  2    |               101). Available at: htt f; See also EU Mercury strategy
145  III,    10.  3.  3    |                 10.3.3.2. Data sources~ ~See Chapter 6.~ ~
146  III,    10.  3.  3    |             Control tools and policies~ ~See Chapter 6.~ ~ ~
147  III,    10.  3.  3    |                 5. Future developments~ ~See Chapter 6.~ ~ ~
148  III,    10.  3.  3    |                   10.3.3.6. References~ ~See Chapter 6.~ ~
149  III,    10.  4.  2    |          important for hazardous agents (see also Section 4.14.2).~ ~
150  III,    10.  4.  2    |              Polychlorobiphenyls~(PCBs); see textbox 4.11~ ~Oils and
151  III,    10.  4.  2    |                1996;~van Loveren, 2002; (see~textbox 4.10)~ ~ ~Mycotoxins:
152  III,    10.  4.  2    |        significant health loss in DALYs (see chapter 9.1).~ ~
153  III,    10.  4.  3    |                  and sanitation systems (see Figure 10.4.3.2).~ ~A special
154  III,    10.  4.  3    |            Brunnsregistret (in Swedish). See: htt ml~Smith AH, et al (
155  III,    10.  4.  4    |                 associated with piercing see Annex 1 of Chapter 5.13.~ ~
156  III,    10.  4.  4    |                  from the manufacturing (see Chapter 8.1.2.) and use
157  III,    10.  4.  4    |                of “product” is involved (see Figure 7.23), the importance
158  III,    10.  4.  4    |                 and adequately enforced (see also Chapter 7). To facilitate
159  III,    10.  4.  4    |       Enforcement Forum (PROSAFE) www g (see also Chapter 7).~ ~ ~
160  III,    10.  4.  5    |                 Environmental Assessment~SEE~South East and Eastern Europe
161  III,    10.  4.  5    |         inadequate storage of chemicals (see Figure 10.4.5.2.1; EEA,
162  III,    10.  4.  5    |                  capita in Russia.~· the SEE countries are estimated
163  III,    10.  4.  5    |               generated in the EECCA and SEE countries is growing due
164  III,    10.  4.  5    |            disposal methods in EECCA and SEE is also not available. However,
165  III,    10.  4.  5    |                  in selected EU-25+EFTA, SEE and EECCA countries 1996-
166  III,    10.  4.  5    |              EU-15. In the three largest SEE countries, Bulgaria, Romania
167  III,    10.  4.  5    |           hazardous waste. All EECCA and SEE countries are party to the
168  III,    10.  5.  1    |                  Legionella Pneumophila (see chapter 6).~ ~Construction
169  III,    10.  5.  1    |           Lebensmittelsicherheit, 2008) (see chapter 6 for fatal and
170  III,    10.  5.  2    |                  road accident injuries (see also Section 8.3.1.)~Different
171  III,    10.  5.  3    |            provided. For fatal accidents see also Chapter 7.~ ~Table
172  III,    10.  5.  3    |                 member states. As we can see, a 20% reduction of accidents
173  III,    10.  5.  3    |                  health (for an overview see Siegrist J & Theorell T,
174  III,    10.  6.  2    |                 studies (for an overview see Berkman and Glass, 2000)~ ~
175  III,    10.  6.  3    |                carried out in Chapter 7 (See figure 7.17).~ ~Contact
176  III,    10.  6.  3    |                 of offences are lacking (see Tables 9.5.5 and 9.5.6).
177   IV,    11.  1.  4    |             Mossialos and Thomson 2003) (see Section 11.6 on Financing
178   IV,    11.  1.  4    |             Mackenbach and Bakker 2002). See also Section 11.4.2 Public
179   IV,    11.  1.  5    |           evidence based practice (EBP) (see also “Appropriateness of
180   IV,    11.  1.  5    |                 Hungary (less than 3.5) (See Figure 11.1). In most countries,
181   IV,    11.  1.  6    |                 or as a form of payment (see Table 11.3). While DRGs
182   IV,    11.  1.  6    |                  heavy state regulation (see Section 11.6 Financing Health
183   IV,    11.  2.  1    |                  beds in many countries (see below). Care outside hospitals
184   IV,    11.  3        |           previous section, here we will see the issues of human resources,
185   IV,    11.  4        |               can work trans-nationally. See www. eu for more information.~ ~
186   IV,    11.  5.  4    |            different European countries (see Figure 11.10). These differences
187   IV,    11.  5.  5    |             actively participate, please see the dedicated website (www ~ ~
188   IV,    11.  6.  2    |            sharing and direct payments) (see below).~ ~European health
189   IV,    11.  6.  2    |                 through tax allocations (see section on Social Health
190   IV,    11.  6.  2    |          Foubister and Mossialos, 2008) (see Section 11.8.3 on Progressivity).~ ~
191   IV,    11.  6.  2    |                 OECD data are collected (see footnote 4).~ ~Social insurance
192   IV,    11.  6.  2    |                  in France in the 1990s (see above). Furthermore, if
193   IV,    11.  6.  2    |           Foubister and Mossialos 2008) (see below for more information
194   IV,    11.  6.  2    |                  out-of-pocket payments (see below). The agents collecting
195   IV,    11.  6.  4    |                   Robinson et al, 2005). See section 11.3.4. Technical
196   IV,    11.  6.  4    |               out of his/her own pocket (see Sections on out-of-pocket
197   IV,    11.  6.  4    |               politicians in this region see comprehensive and free healthcare
198   IV,    11.  6.  4    |                from providers, who would see a reduction in income, being
199   IV,    12.  1        |                provisions of the Treaty (see Table 12.3), related to
200   IV,    12.  2        |                  health in all policies (see also Chapter 11.5) and global
201   IV,    12.  2        |                 All Policiesprinciple (see Section 12.7.), and is likely
202   IV,    12.  2        |             policies. For some examples, see Tables 12.4 and 12.5.~ ~
203   IV,    12.  2        |                     For more information see:~htt ~ ~
204   IV,    12.  5        |            Information Network (EUPHIN) (see also the EUPHIN newsletter).
205   IV,    12.  5        |                their collection and use (see Annex 12.1).~ ~ ~Annex 12.
206   IV,    12.  7        |                policies. Yet, we have to see this principle implemented,
207   IV,    12. 10        |                  also at European level (see Annex 12.3). Through their
208   IV,    12. 10        |         developments at Community level (see Annex 12.3).~ ~Annex 12.
209   IV,    12. 10        |            within the healthcare sector.~See more: htt 8~ 2002-2010:
210   IV,    12. 10        |             healthy diet and food safety~See more: htt ~ ~Physical stressors~
211   IV,    12. 10        |                by Robert Koch-Institute (see www.rki.de); Drug Affinity
212   IV,    12. 10        |             Centre for Health Education, see www. ). Socio-Economic Panel
213   IV,    12. 10        |             study of private households, see www. l) and Census Data
214   IV,    12. 10        |              Federal Statistical Office (see www. e) are other information
215   IV,    12. 10        |                 Public Health Reporting (see www.rki.de).~ List of ingredients
216   IV,    12. 10        |                 and consumer protection (see www. ).~Federal Centre for
217   IV,    12. 10        |                and children/adolescents (see e. g. www o) including quit-lines (
218   IV,    12. 10        |                 Be smartdont start” (see www. ), smoke-stop competitions
219   IV,    12. 10        |             WHO-initiative “Quit & Win”, see www.rauchfrei2008.de), basic
220   IV,    12. 10        |          children (“Kinder stark machen” see www. ), school-based health
221   IV,    12. 10        |            Cancer Research Centre (DKFZ, see www. - German Cancer Aid (
222   IV,    12. 10        |                by Robert Koch-Institute (see www. e) and Drug Affinity
223   IV,    12. 10        |             Centre for Health Education (see www. .~ Alcohol prevention
224   IV,    12. 10        |                 Bundesdrogenbeauftragte, see www.bmg.bund.de), Federal
225   IV,    12. 10        |                  Health Education (BzGA, see www. e) and German Center
226   IV,    12. 10        |             Hauptstelle für Suchtfragen, see www. ). Several information
227   IV,    12. 10        |            employees concerning alcohol (see www. ).~Detoxification,
228   IV,    12. 10        |                   for a list of projects see www. ~ ~Food choices and
229   IV,    12. 10        |                  meet the law’s criteria see www. de~National action
230   IV,    12. 10        |                interviews, respectively; see http ). Dietary habits of
231   IV,    12. 10        |                 National Health Surveys (see www.rki.de).~ ~Nutritional
232   IV,    12. 10        |                  Health Education (BZgA, see www. ), Nationaler Aktionsplan "
233   IV,    12. 10        |                   Women and Adolescents (see www. ).~Further resources
234   IV,    12. 10        |             easy-peasy” (“Kinderleicht”, see www. – supported by Federal
235   IV,    12. 10        |                  Protection).~“FIT KID” (see www. – healthy food at day-care
236   IV,    12. 10        |                craze (“Life has weight”, see www. ), self-help projects
237   IV,    12. 10        |             therapy of eating disorders (see www. – “Research association
238   IV,    12. 10        |            obesity or diabetes mellitus (see above).~National governmental
239   IV,    12. 10        |                 according to § 20 SGB V (see above) and of different
240   IV,    12. 10        |                 subgroups like children, see www. e) is part of national
241   IV,    12. 10        |               national health reporting (see www.rki.de).~ Selected activities:~
242   IV,    12. 10        |                Bewegung und Gesundheit”, see www. – promotes3000 footsteps
243   IV,    12. 10        |                 Deutschland bewegt sich, see www. – cooperation of a
244   IV,    12. 10        |             Nationaler Radverkehrsplan”, see www. de or www. , “Support
245   IV,    12. 10        |                Sportstättenbauförderung, see www. ~ ~Drugs and substance
246   IV,    12. 10        |            Aktionsplan Drogen und Sucht, see www.bmg.bund.de) serves
247   IV,    12. 10        |                 Bundesdrogenbeauftragte, see www.bmg.bund.de), Federal
248   IV,    12. 10        |                  Health Education (BzGA, see www. e) and German Center
249   IV,    12. 10        |             Hauptstelle für Suchtfragen, see www. ). Several information
250   IV,    12. 10        |             Health and 8 federal states, see http .~“JES – junkies, ex-user
251   IV,    12. 10        |                 AIDS Support Federation, see www.jes.aidshilfe.de.~For
252   IV,    12. 10        |                  For further information seeDrugs and Addiction Report”
253   IV,    12. 10        |           Coordinator (annually release, see www. e) and http / (European
254   IV,    12. 10        |                Health Education (BZgA), (see www. e) aims to prevent
255   IV,    12. 10        |                during the last 10 years (see www. ).~Institutions and
256   IV,    12. 10        |          Arzneimitteltherapiesicherheit, see www. ).~Federal Institute
257   IV,    12. 10        |                  Medizinprodukte, BfArM, see www. e) is working on safety
258   IV,    12. 10        |               der deutschen Ärzteschaft, see www. e) is an independent
259   IV,    12. 10        |     online-reporting of critical events, see www. de and www. de~Institutions
260   IV,    12. 10        |                Verbraucherschutz, BMELV, see www. e)~Federal Office of
261   IV,    12. 10        |             Lebensmittelsicherheit, BVL, see www. – responsible for safe
262   IV,    12. 10        |                für Risikobewertung, BfR, see www. - agency under public
263   IV,    12. 10        | Verbraucherzentrale Bundesverband, VZBV, see www. - umbrella organization
264   IV,    12. 10        |             testing (Stiftung Warentest, see www. – independent foundation
265   IV,    12. 10        |              traffic, and working safety see homepages of Federal Ministries
266   IV,    12. 10        |                  improve patient safety, see www. e~„Forum Patient safety“ –
267   IV,    12. 10        |           Qualität in der Medizin, ÄZQ), see www. ~ ~Environmental determinants
268   IV,    12. 10        |                Verbraucherschutz, BMELV, see www. e)~Federal Office of
269   IV,    12. 10        |             Lebensmittelsicherheit, BVL, see www. – responsible for safe
270   IV,    12. 10        |                für Risikobewertung, BfR, see www. - agency under public
271   IV,    12. 10        |              Adolescents, since 04/2007, see www. e, within the framework
272   IV,    12. 10        |               their health consequences”~See comments 10.2.4 and 10.2.
273   IV,    12. 10        |                 National Health Surveys (see www. ~ ~Genomics and public
274   IV,    12. 10        |             Lebensmittelsicherheit, BVL, see www. - federal authority
275   IV,    12. 10        |               usual approval procedures (see Federal Institute for Drugs
276   IV,    12. 10        |                   Paul-Ehrlich-Institut, see www. ). For additional information
277   IV,    12. 10        |               For additional information see e. g. German Registry for
278   IV,    12. 10        |       Gentherapie der Bundesärztekammer, see www. e)~Usage of stem cells
279   IV,    12. 10        |        references to bioethical subjects see e. g. Federal Ministry of
280   IV,    12. 10        |                by Robert Koch-Institute (see www. ~ ~B) Actions adopted
281   IV,    12. 10        |                2007~Chemicals Bills 2008~See www. ie and www. ie~Public
282   IV,    12. 10        |                  For further information see~http ie~Physical stressors~
283   IV,    12. 10        |                  Protection Agency~ ~ ~ ~See www. ie~Process of consultation
284   IV,    12. 10        |                 No specific regulations~ See poverty~Others~ ~ ~ ~Psychosocial
285   IV,    12. 10        |             settlements~ intermediate~ ~ See air pollution and physical
286   IV,    12. 10        |             Deprivation factors~ high~ ~ See poverty also: special attention
287   IV,    12. 10        |          diabetes, health of youth, aidssee: htt ~ ~As regards reports,
288   IV,    12. 10        |              settlements~ intermediate~ ~See air pollution and physical
289   IV,    13.  1        |            magnitude (for mortality data see Table 13.3). Large differences
290   IV,    13.  4        |                  For further information see http ~ ~
291   IV,    13.  6.  2    |                 age-group paediatricians see varies in each country.
292   IV,    13.  7.  2    |     environmental and societal benefits (see the LMI Communication).~ ~
293   IV,    13.  7.  5    |           Throughout this report one can see the need to have comparable